4.4 Article

Effectiveness of Pfizer-BioNTech and Moderna Vaccines in Preventing SARS-CoV-2 Infection Among Nursing Home Residents Before and During Widespread Circulation of the SARS-CoV-2 B.1.617.2 (Delta) Variant — National Healthcare Safety Network, March 1–August 1, 2021

Related references

Note: Only part of the references are listed.
Article Public, Environmental & Occupational Health

The Advisory Committee on Immunization Practices' Updated Interim Recommendation for Allocation of COVID-19 Vaccine - United States, December 2020

Kathleen Dooling et al.

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2021)

Article Public, Environmental & Occupational Health

Rates of COVID-19 Among Residents and Staff Members in Nursing Homes — United States, May 25–November 22, 2020

Suparna Bagchi et al.

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2021)

Editorial Material Medicine, General & Internal

First-Dose COVID-19 Vaccination Coverage Among Skilled Nursing Facility Residents and Staff

Radhika Gharpure et al.

Summary: This JAMA Insights review presents data on the number of long-term care facilities and the numbers of residents and staff who received first-dose vaccination through the public-private partnership with CVS, Walgreens, and Managed Health Care Associates. This data helps understand the progress of vaccination.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)

Article Infectious Diseases

Effectiveness of mRNA COVID-19 vaccines in preventing SARS-CoV-2 infections and COVID-19 hospitalisations and deaths in elderly long-term care facility residents, Spain, weeks 53 2020 to 13 2021

Clara Mazagatos et al.

Summary: The study found that the effectiveness of mRNA COVID-19 vaccines for elderly residents in long-term care facilities in Spain was estimated at 71%, 88%, and 97% against SARS-CoV-2 infections, COVID-19 hospitalizations, and deaths, respectively.

EUROSURVEILLANCE (2021)